The Roundup – March 6, 2024
View this email in your browser March 6, 2024 Member News Arvinas appoints Noah Berkowitz, M.D., Ph.D., as Chief Medical Officer Aspira Women’s Health expands senior leadership...
Home >
Access the latest news, business developments, company updates, industry trends, events and more.
View this email in your browser March 6, 2024 Member News Arvinas appoints Noah Berkowitz, M.D., Ph.D., as Chief Medical Officer Aspira Women’s Health expands senior leadership...
View this email in your browser March 14, 2024 Member News Boehringer Ingelheim and Sosei Heptares join forces to develop first-in-class treatments targeting all symptoms of...
View this email in your browser We’re excited to announce applications are open for Boehringer Ingelheim Office Hours (May 1) at their US headquarters in Ridgefield, CT....
View this email in your browser March 7, 2024 Member News Allyx Therapeutics announces expansion into Parkinson’s Disease clinical research with lead compound ALX-001 following IND...
View this email in your browser February 29, 2024 Member News Arvinas moves ahead with 2 new drugs BIO: What policy biotech should be watching this election...
View this email in your browser February 22, 2024 Member News Ancera: Monitoring system can help producers manage coccidiosis Arvinas Announces first-in-human dosing of ARV-102, an...
View this email in your browser February 15, 2024 Member News A new class of cancer drugs is coming: Pfizer & Arvinas‘ hot pursuit of protein degrader technology...
View this email in your browser February 8, 2024 Member News Arvinas and Pfizer’s Vepdegestrant (ARV-471) receives FDA fast track designation for the treatment of patients with...
View this email in your browser We are thrilled to extend a special invitation to the upcoming Connecticut Rare Disease Forum, hosted by BioCT and The Jackson...
View this email in your browser February 1, 2024 Member News Over 20 CT companies included in America’s Greatest Workplaces for Diversity 2024 (Boehringer Ingelheim, Pfizer)...